It has been demonstrated that the inhibition of SLC7A11 by p53 resulted in the reduction of glutathione (GSH), which promoted the ferroptosis and tumor suppression both in vitro and in vivo4-6. This evidence concerns the gene SLC7A11 and neoplasm.